You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 296 No. 12, September 27, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Evidence-Based Medicine
 •Randomized Controlled Trial
 •Hypertension
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Clinical Trials in Hypertension—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: The meta-analysis that we conducted in 19971 included the available evidence from placebo-controlled trials of beta-blockers and diuretics. Dr Messerli and colleagues question whether the findings of Lindholm et al2 actually confirm ours. Regarding the placebo-controlled trials of beta-blockers, our findings agree with Figure 2A in Lindholm et al. For example, in both meta-analyses, beta-blockers compared with placebo were associated with a reduced risk of stroke but not coronary disease.1-2 The 1997 JNC 6 recommendations3 were appropriately evidence-based, using the clinical trial findings of an actual health benefit as evidence.

The 1997 meta-analysis1 also drew attention to the importance of low-dose diuretics, which were associated with decreased risks of stroke, coronary disease, heart failure, and total mortality. Our more recent 2003 meta-analysis4 provided additional evidence about the efficacy and safety of low-dose diuretic therapy, which led us to conclude that low-dose diuretics are the most effective first-line treatment . . . [Full Text of this Article]

Bruce M. Psaty, MD, PhD
psaty@u.washington.edu
Department of Medicine

Noel S. Weiss, MD, DrPH, MPH
Department of Epidemiology
University of Washington
Seattle

Curt D. Furberg, MD, PhD
Wake Forest University School of Medicine
Winston-Salem, NC



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED ARTICLES

Clinical Trials in Hypertension
Franz H. Messerli, Gareth Beevers, Stanley S. Franklin, and Thomas G. Pickering
JAMA. 2006;296(12):1463.
EXTRACT | FULL TEXT  

Clinical Trials in Hypertension
Simeon Pollack
JAMA. 2006;296(12):1464.
EXTRACT | FULL TEXT  

Recent Trials in Hypertension: Compelling Science or Commercial Speech?
Bruce M. Psaty, Noel S. Weiss, and Curt D. Furberg
JAMA. 2006;295(14):1704-1706.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.